The timing of the intervention may be the deciding factor
Patients with severe abdominal pain, pain which radiates to the back, with or without vomiting should be assessed for pancreatitis [11]
However, tirzepatide may cause higher rates of gastrointestinal side effects, particularly during the initial dose titration stage
While Wegovys 7.2 mg dose remains under regulatory review and is not yet standard practice, these findings highlight that patients considering a switch may be able to achieve results that are highly comparable to those seen with Mounjaro, offering another strong option in pharmacological obesity management
During this time, you may start to see a decrease in your appetite and the intensity of your hunger cues, which can lead to steady, healthy weight loss over time